No adverse reactions occurred in greater than 5% of patients receiving ceftaroline. The most common adverse reactions occurring in > 2% of patients receiving ceftaroline in the pooled phase-III clinical trials were:<ref name="drug information online" />

 


 
* [[Diarrhea]]

 
* [[Nausea]]

 
* [[Rash]]

 

